Wnt/β-catenin signalling in prostate cancer

被引:0
|
作者
Robert M. Kypta
Jonathan Waxman
机构
[1] Cell biology and Stem Cells Unit,Department of Surgery and Cancer
[2] Center for Cooperative Research in Biosciences,undefined
[3] CIC bioGUNE,undefined
[4] Imperial College London,undefined
来源
Nature Reviews Urology | 2012年 / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dysregulation of Wnt signalling, a hallmark of which is the stabilization of the transcriptional co-activator β catenin, can lead to several types of cancer, including prostate cancer. Activation of the Wnt/β catenin pathway has effects on prostate cell proliferation, differentiation and the epithelial–mesenchymal transition. In this Review, the authors discuss how the pathway is activated and consider the possible therapeutic application of drugs that target Wnt/β catenin signalling.
引用
收藏
页码:418 / 428
页数:10
相关论文
共 50 条
  • [1] Wnt/β-catenin signalling in prostate cancer
    Kypta, Robert M.
    Waxman, Jonathan
    [J]. NATURE REVIEWS UROLOGY, 2012, 9 (08) : 418 - 428
  • [2] β-catenin in Wnt signalling and cancer
    Huber, O
    [J]. CELL ADHESION MOLECULES IN HEALTH AND DISEASE, 2003, : 145 - 153
  • [3] β-catenin signalling in prostate cancer
    Dulinska-Litewka, Joanna
    Dudzik, Paulina
    Hryniewicz, Iwona
    Okon, Krzysztof
    Laidler, Piotr
    [J]. BJU INTERNATIONAL, 2013, 112 : 52 - 53
  • [4] Wnt signalling and prostate cancer
    G W Yardy
    S F Brewster
    [J]. Prostate Cancer and Prostatic Diseases, 2005, 8 : 119 - 126
  • [5] WNT signalling in prostate cancer
    Murillo-Garzon, Virginia
    Kypta, Robert
    [J]. NATURE REVIEWS UROLOGY, 2017, 14 (11) : 683 - 696
  • [6] WNT signalling in prostate cancer
    Virginia Murillo-Garzón
    Robert Kypta
    [J]. Nature Reviews Urology, 2017, 14 : 683 - 696
  • [7] Wnt signalling and prostate cancer
    Yardy, GW
    Brewster, SF
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (02) : 119 - 126
  • [8] β-catenin and wnt signalling partners in oral cancer
    Papagerakis, S.
    Papagerakis, P.
    Slaga, T.
    Fearon, E.
    Carey, T. E.
    [J]. ORAL ONCOLOGY, 2007, : 64 - 64
  • [9] LYRIC, a novel modulator of Wnt/fO-catenin and androgen receptor signalling in prostate cancer
    Neal, D.
    Whitaker, H.
    Mills, I.
    Vias, M.
    [J]. BJU INTERNATIONAL, 2008, 101 : 32 - 32
  • [10] WNT/β-CATENIN SIGNALLING IS A POTENTIAL THERAPEUTIC TARGET FOR CASTRATE-RESISTANT PROSTATE CANCER.
    Kawano, Yoshiaki
    Maeda, Yoshihiro
    Motoshima, Takanobu
    Imamura, Takahisa
    Takahashi, Wataru
    Wada, Yoshihiro
    Kypta, Robert
    Eto, Masatoshi
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E504 - E505